Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2008
12/11/2008WO2008149191A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/11/2008WO2008149110A1 Bicyclor [2.2.1] hept-7-ylamine derivatives and their use in the treatment of diseases and conditions in which m3 muscarinic receptor activity and beta-adrenergic activity are implicated
12/11/2008WO2008148710A2 Aryloxazole, aryloxadiazole and benzimidazole derivatives as modulators of somatostatins receptor activity
12/11/2008WO2008148449A1 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors
12/11/2008WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety
12/11/2008WO2008016522A3 Hiv reverse transcriptase inhibitors
12/11/2008WO2007092364A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment
12/11/2008US20080306279 Synthesis Intermediates Useful For Preparing Zolmitriptan
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306129 Benzimidazoles useful as modulators of ion channels
12/11/2008US20080306127 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
12/11/2008US20080306121 Bisheterocycle Tandem Compounds Useful as Antiviral Agents, the Uses Thereof and the Compositions Comprising Such Compounds
12/11/2008US20080306101 Insecticidal Spironindane Derivatives
12/11/2008US20080306091 2-Amino-5-[3-(2fluoropyridin-3-yl)phenyl]-3methyl-5-[3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]-3,5-dihydro-4H-imidazol-4-one; Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy, neurofibrillary tangles, beta -amyloid deposits
12/11/2008US20080306088 7-chloro-5-(5-piperazin-1-ylmethyl-[1,2,4]oxadiazol-3-yl)-2-(4-trifluoromethoxybenzyl)-2,3-dihydroisoindol-1-one, for the treatment of nervous system disorders and psychological disorders
12/11/2008US20080306077 Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators 842
12/11/2008US20080306071 Substituted piperidine compounds and methods of their use
12/11/2008US20080306069 Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S
12/11/2008US20080306067 Modulators of Chemokine Receptor Activity
12/11/2008US20080306066 Non-imidazole heterocyclic compounds
12/11/2008US20080306065 Metalloproteinase Inhibitors
12/11/2008US20080306064 Benzimidazole Derivatives
12/11/2008US20080306062 Modulators of atp-binding cassette transporters
12/11/2008US20080306061 Aminophenylsulfonamide Derivatives as Hiv Protease Inhibitor
12/11/2008US20080306060 Fused Thiazole Derivatives as Kinase Inhibitors
12/11/2008US20080306056 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
12/11/2008US20080306049 Therapeutic pyrazoloquinoline derivatives
12/11/2008US20080306048 Therapeutic pyrazoloquinoline urea derivatives
12/11/2008US20080306041 Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
12/11/2008DE102007026341A1 Benzoxazolonderivate Benzoxazolonderivate
12/11/2008DE102007025717A1 Arylether-pyridazinonderivate Aryl ether pyridazinone derivatives
12/11/2008CA2693552A1 Pyridone compound
12/11/2008CA2690856A1 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842
12/11/2008CA2690101A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/11/2008CA2689554A1 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours
12/11/2008CA2688594A1 Aryloxazole, aryloxadiazole and benzimidazole derivatives
12/10/2008EP2000465A1 Triazolone derivative
12/10/2008EP1999120A1 Benzothiazoles having histamine h3 receptor activity
12/10/2008EP1999119A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
12/10/2008EP1999117A2 Renin inhibitors
12/10/2008EP1999114A2 Pyrazoles as 11-beta-hsd-1
12/10/2008EP1753757B1 Substituted 2,5-diaminomethyl-1h-pyrroles
12/10/2008EP1673085A4 C-met modulators and methods of use
12/10/2008EP1396487B1 Phenylpyridine carbonyl piperazine derivative
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/10/2008CN101321766A Substituted benzofused derivatives and their use as vanilloid receptor ligands
12/10/2008CN101321731A Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
12/10/2008CN101321525A Heteroaryl substituted piperidine derivatives as L-CPT1 inhibitors
12/10/2008CN100441571C Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
12/10/2008CN100441185C 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
12/09/2008US7462717 e.g. 3-{4-[3-(4-fluoro-phenyl)-2-methyl-allyl]-piperazin-1-ylmethyl}-7,8-dimethoxy-3a,4-dihydro-3H-chromeno [4,3-c]isoxazol-6-yl)-pyridin-4-yl-amine; serotonin (5-HT) reuptake inhibitor and alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; psycosis, Parkinson's disease
12/09/2008US7462637 Derivatives of [6,7-dihydro-5H-imidazo[1,2--a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
12/09/2008US7462636 Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
12/09/2008US7462635 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia
12/09/2008US7462633 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/09/2008US7462616 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
12/09/2008US7462204 Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds
12/09/2008CA2453946C Process for the preparation of 3-spiro[cyclohexam-1,3'-[3h]indolin-2'-one] derivatives
12/09/2008CA2337804C Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
12/04/2008WO2008147697A1 Benzimidazolone chymase inhibitors
12/04/2008WO2008147518A1 Pyridyl piperidine orexin receptor antagonists
12/04/2008WO2008146774A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008WO2008146172A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008WO2008145681A2 Ccr2 receptor antagonists and uses thereof
12/04/2008WO2008145243A1 Pyridazinone derivatives
12/04/2008WO2008145242A1 Aryl ether pyridazinone derivatives
12/04/2008WO2008126024A3 Oxazolidinone antibiotic derivatives
12/04/2008WO2008119771A3 Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
12/04/2008WO2008115973A3 Aminopyrimidines useful as kinase inhibitors
12/04/2008WO2008104512A3 Novel polymorphs of aprepitant and processes for preparation
12/04/2008WO2008062905A3 Heteromonocyclic compound and use thereof
12/04/2008US20080300404 Process for the Preparation of Mycophenolate Mofetil
12/04/2008US20080300403 Method for Production of Quinolone-Containing Lyophilized Preparation
12/04/2008US20080300288 Alkenyldiarylmethanes, Fused Analogs And Syntheses Thereof
12/04/2008US20080300248 Quinazoline Derivatives, Preparation Methods and Uses Thereof
12/04/2008US20080300247 Benzimidazole Thiophene Compounds
12/04/2008US20080300246 Compounds and Compositions as Protein Kinase Inhibitors
12/04/2008US20080300239 Quinoline derivatives as pi3 kinase inhibitors
12/04/2008US20080300234 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
12/04/2008US20080300232 N-Piperidine Derivatives as Ccr3 Modulators
12/04/2008US20080300138 Dioxazinyl-Substituted Thienylsulphonylaminocarbonyl Compounds
12/04/2008US20080299639 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
12/04/2008US20080299076 Compunds and compositions that cause non-apoptotic cell death and uses thereof
12/04/2008DE102007025718A1 Pyridazinonderivate Pyridazinone derivatives
12/04/2008CA2688599A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008CA2688518A1 Pyridazinone derivatives for use in the treatment of a disease which is influenced by inhibiton of met kinase
12/04/2008CA2688517A1 Aryl ether pyridazinone derivatives for use in the treatment of tumours
12/04/2008CA2688326A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008CA2687931A1 Ccr2 receptor antagonists and uses thereof
12/04/2008CA2687821A1 Benzimidazolone chymase inhibitors
12/04/2008CA2687321A1 Pyridyl piperidine orexin receptor antagonists
12/04/2008CA2687132A1 4' substituted compounds having 5-ht6 receptor affinity
12/03/2008EP1997856A1 Optical recording medium and azo metal chelate compound
12/03/2008EP1997813A1 Substituted isoxazoline compound and pest control agent
12/03/2008EP1997811A2 Indazole, benzoxazole and pyrazolopyridine derivatives as P38 kinase inhibitors
12/03/2008EP1997810A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997809A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997805A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/03/2008EP1996588A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors